Rapid Dose Therapeutics Corp. (CSE: DOSE)
Canada
· Delayed Price · Currency is CAD 0.190
-0.005 (-2.56%)
Jan 21, 2025, 9:56 AM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 515.92K CAD in the quarter ending August 31, 2024, with 46.08% growth. This brings the company's revenue in the last twelve months to 1.34M, up 20.09% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.34M
Revenue Growth
+20.09%
P/S Ratio
14.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Trulieve Cannabis | 1.58B |
| Sienna Senior Living | 867.55M |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |